We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Antioxidant Treatment of Type 2 Diabetes

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00609102
First Posted: February 6, 2008
Last Update Posted: December 24, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
January 23, 2008
February 6, 2008
December 24, 2014
July 2008
September 2013   (Final data collection date for primary outcome measure)
Blood glucose [ Time Frame: 3 months ]
Same as current
Complete list of historical versions of study NCT00609102 on ClinicalTrials.gov Archive Site
HbA1c levels [ Time Frame: 3 months ]
Same as current
Not Provided
Not Provided
 
Antioxidant Treatment of Type 2 Diabetes
Not Provided
This study examines whether an antioxidant taken orally will improve glucose tolerance and insulin secretion in type 2 diabetic subjects.
Not Provided
Interventional
Early Phase 1
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Single (Participant)
Primary Purpose: Treatment
Type 2 Diabetes
  • Drug: Placebo
    one capsule BID
  • Drug: n-aceylcysteine
    450 mgm BID
  • Placebo Comparator: Placebo
    Intervention: Drug: Placebo
  • Active Comparator: antioxidant drug
    n-acetylcysteine
    Intervention: Drug: n-aceylcysteine
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
44
September 2013
September 2013   (Final data collection date for primary outcome measure)

Inclusion Criteria: Subjects with a known diagnosis of type 2 diabetes -

Exclusion Criteria: None, except known intolerance to n-acetylcysteine

Sexes Eligible for Study: All
18 Years to 70 Years   (Adult, Senior)
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00609102
Antioxidant trmt type 2
NIH R01 38325-19
Not Provided
Not Provided
Not Provided
R. Paul Robertson, Pacific Northwest Research Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Not Provided
Not Provided
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
December 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP
To Top